Premier Biomedical, Halberd and Gold River Agree to Work Jointly to Develop Premier’s Patented Extracorporeal Technology on COVID-19 Treatment And Proprietary Anti-Addiction PatchTM
Jackson Center, PA, April 8, 2020 – Premier Biomedical, Inc. (OTC-PINK: “BIEI“), Halberd Corporation (OTC-PINK: HALB) and Gold River Productions Inc. (OTC-PINK: GRPS) announce the signing of a multi-faceted agreement for ongoing R&D into a potential treatment and cure for Covid-19 as well as development of Premier’s Anti-Addiction PatchTM. The Joint Venture on Covid-19 treatment starts with Dr. Mitchell ...